Sagimet Biosciences Inc (NASDAQ: SGMT) started the day on Thursday, with a price decrease of -3.43% at $5.07, before settling in for the price of $5.25 at the close. Taking a more long-term approach, SGMT posted a 52-week range of $2.39-$20.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -16.23%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 44.34%. This publicly-traded company’s shares outstanding now amounts to $30.67 million, simultaneously with a float of $20.41 million. The organization now has a market capitalization sitting at $155.52 million. At the time of writing, stock’s 50-day Moving Average stood at $5.26, while the 200-day Moving Average is $4.28.
Sagimet Biosciences Inc (SGMT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Sagimet Biosciences Inc’s current insider ownership accounts for 36.62%, in contrast to 47.17% institutional ownership. According to the most recent insider trade that took place on Jul 23 ’24, this organization’s Executive Chairman sold 23,625 shares at the rate of 3.17, making the entire transaction reach 74,830 in total value, affecting insider ownership by 118,693. Preceding that transaction, on Jul 19 ’24, Company’s Chief Medical Officer sold 8,357 for 3.10, making the whole transaction’s value amount to 25,910. This particular insider is now the holder of 81,213 in total.
Sagimet Biosciences Inc (SGMT) Earnings and Revenue Records
Sagimet Biosciences Inc’s EPS increase for this current 12-month fiscal period is 44.34% and is forecasted to reach -3.49 in the upcoming year.
Sagimet Biosciences Inc (NASDAQ: SGMT) Trading Performance Indicators
Let’s observe the current performance indicators for Sagimet Biosciences Inc (SGMT). It’s Quick Ratio in the last reported quarter now stands at 38.34. The Stock has managed to achieve an average true range (ATR) of 0.58.
In the same vein, SGMT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.29, a figure that is expected to reach -0.57 in the next quarter, and analysts are predicting that it will be -3.49 at the market close of one year from today.
Technical Analysis of Sagimet Biosciences Inc (SGMT)
If we take a close look at the recent performances of Sagimet Biosciences Inc (NASDAQ: SGMT), its last 5-days Average volume was 1.64 million that shows progress from its year to date volume of 1.08 million. During the previous 9 days, stock’s Stochastic %D was recorded 51.06% While, its Average True Range was 0.62.
Raw Stochastic average of Sagimet Biosciences Inc (SGMT) in the period of the previous 100 days is set at 66.17%, which indicates a major rise in contrast to 34.27% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 146.22% that was higher than 112.07% volatility it exhibited in the past 100-days period.
